483 Document: Cangene bioPharma, Inc. dba Emergent BioSolutions, Apr 9, 2014

FDANews 483 Cangene bioPharma, Inc. dba Emergent BioSolutions Apr 9 2014 top
Jonathan W. Chapman FDA Investigator Brooke K. Higgins FDA Investigator

On Apr 09, 2014, the FDA inspected Cangene bioPharma, Inc. dba Emergent BioSolutions's Baltimore site. Explore the inspectional observations.